Optimal timing for elective egg freezing

Slides:



Advertisements
Similar presentations
International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003  Karl G. Nygren,
Advertisements

Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Grace Younes, M.D., Togas Tulandi, M.D., M.H.C.M. 
Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc
Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 
Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage 
Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis  Claire F. la Chapelle, M.D., Sebastiaan.
Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology.
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Infertility evaluation and treatment among women in the United States
Samuel Santos-Ribeiro, M. D. , Johannie Siffain, M. D. , Nikolaos P
Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States  Jennifer.
Long-term risk of ectopic pregnancy varies by method of tubal sterilization: a whole- population study  Eva Malacova, Ph.D., Anna Kemp, Ph.D., Roger Hart,
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Association of physical activity in the past year and immediately after in vitro fertilization on pregnancy  Kelly R. Evenson, Ph.D., M.S., Kathryn C.
Adherence compounds in embryo transfer media for assisted reproductive technologies: summary of a Cochrane review  Stephan Bontekoe, M.D., Neil Johnson,
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day.
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth  Kate Devine, M.D., Sunni L. Mumford, Ph.D., Kara.
Live birth of twins derived from zona-free oocytes
Management of the first in vitro fertilization cycle for unexplained infertility: a cost- effectiveness analysis of split in vitro fertilization-intracytoplasmic.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Optimizing natural fertility: a committee opinion
Oocyte cryopreservation
Lena Dain, M. D. , David Bider, M. D. , Jacob Levron, M. D
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS  Judy E. Stern,
Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle  Nancy J. Kenney,
Limitations on the compensation of gamete donors: a public opinion survey  Malinda S. Lee, M.D., M.B.A., Leslie V. Farland, Sc.D., Stacey A. Missmer, Sc.D.,
Increased risk of pregnancy-induced hypertension and operative delivery after conception induced by in vitro fertilization/intracytoplasmic sperm injection.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles  Eva R. Groenewoud, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States  Judy E. Stern, Ph.D., Marcelle I.
Interaction of apolipoprotein E gene polymorphisms on miscarriage risk in black and white American women  Silvia Gamundi-Segura, M.Sc., Elena Torres-Perez,
Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low.
Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis  Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,
Stephanie L. F. Gustin, M. D. , Gourab Mukherjee, Valerie L. Baker, M
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
Jennifer F. Kawwass, M. D. , Sara Crawford, Ph. D. , Donna R
Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.
One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above  Sigal Klipstein, M.D., Meredith.
First cesarean birth and subsequent fertility
Aaron K. Styer, M. D. , Diane L. Wright, Ph. D. , H. C. L. D. , Anne M
Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success  J. Ryan Martin, M.D., Jason G. Bromer,
Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation  Allison Styne-Gross, M.D., Karen.
Optimizing natural fertility
Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic.
Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation  Lauren B. Messinger, M.D., Connie E. Alford,
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
International Committee for Monitoring Assisted Reproductive Technologies: World Report on Assisted Reproductive Technologies, 2007  Osamu Ishihara, M.D.,
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows  Jessica.
Genetic evaluation procedures at sperm banks in the United States
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles  Inna Berin, M.D., Lawrence L. Engmann, M.D., Claudio.
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
In vitro sildenafil citrate use as a sperm motility stimulant
Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc
Contact among families who share the same sperm donor
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Optimizing natural fertility: a committee opinion
Is chromosome testing of the second miscarriage cost saving
The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women  Beth A. Malizia, M.D., Laura.
Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.
Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles  John L. Frattarelli,
Presentation transcript:

Optimal timing for elective egg freezing Tolga B. Mesen, M.D., Jennifer E. Mersereau, M.D., M.S.C.I., Jennifer B. Kane, Ph.D., Anne Z. Steiner, M.D., M.P.H.  Fertility and Sterility  Volume 103, Issue 6, Pages 1551-1556.e4 (June 2015) DOI: 10.1016/j.fertnstert.2015.03.002 Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Simplified decision tree for model A. For a simplified representation of the decision tree, chance nodes for probability of second and third cycles from frozen oocytes, first and second (FET), and miscarriage are not shown. Analyses were repeated for decision ages from 25 to 40 years, assuming a 7-year time horizon before attempting pregnancy. In model A (requiring marriage to attempt conception), those who did not marry did not attempt pregnancy. In model B, all women attempt pregnancy, either with a partner or with donor sperm. Solid square denotes decision node; open circles denote chance nodes. Fertility and Sterility 2015 103, 1551-1556.e4DOI: (10.1016/j.fertnstert.2015.03.002) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 2 The y axis represents the probability of live birth at horizon age, which is 7 years after decision age. Decision age is presented on the x axis. Solid lines: oocyte cryopreservation (OC). Dashed lines: no action. Model A (red) represents women requiring marriage before attempting pregnancy. Model B (black) represents women who do not require marriage before attempting pregnancy (will attempt pregnancy with husband, donor sperm, or unmarried male partner). Fertility and Sterility 2015 103, 1551-1556.e4DOI: (10.1016/j.fertnstert.2015.03.002) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Cost per additional live birth at horizon age when electing to cryopreserve oocytes versus no action at decision age, which is presented on the x axis. Model A represents women requiring marriage before attempting pregnancy. Model B represents women who do not require marriage before attempting pregnancy (will attempt pregnancy with husband, donor sperm, or unmarried male partner). Fertility and Sterility 2015 103, 1551-1556.e4DOI: (10.1016/j.fertnstert.2015.03.002) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 The y axis represents the probability of occurrence at horizon age, which is 7 years after decision age. The x axis represents the decision age. Dashed lines in A–E represent error used in sensitivity analyses. Dotted portion of line in B represents projected data. For simplicity, variable errors are not graphed in F and G. Fertility and Sterility 2015 103, 1551-1556.e4DOI: (10.1016/j.fertnstert.2015.03.002) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 2 The y axis represent the probability of live birth at (A) 3- and (B) 5-year horizon age. Decision age is presented on the x axis. Solid lines: oocyte cryopreservation (OC). Dashed lines: no action. Model A represents women requiring marriage before attempting pregnancy. Model B represents women who do not require marriage before attempting pregnancy (will attempt pregnancy with husband, donor sperm, or unmarried male partner). Fertility and Sterility 2015 103, 1551-1556.e4DOI: (10.1016/j.fertnstert.2015.03.002) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions